The Xi'an Experience of Kawasaki Disease - Lessons Learnt over 5 years

Fuyong Jiao1, Xiaohua Yan2, Xiaofang Wu3

  • 1Children's Hospital, Shaanxi Provincial People's Hospital, Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China. jiaofy@yeah.net.

Insights

Kawasaki disease (KD), a serious condition causing inflammation in children's blood vessels, is increasingly diagnosed in China. This study details experiences with 170 pediatric KD cases, offering crucial data for treatment.

Area of Science:

  • Pediatrics
  • Rheumatology
  • Cardiology

Background:

  • Kawasaki disease (KD), or mucocutaneous lymph node syndrome, is an acute febrile illness characterized by systemic vasculitis.
  • It predominantly affects children under five and is a leading cause of acquired heart disease in developed nations.
  • While KD diagnosis is rising in China, comprehensive data remains limited.

Purpose of the Study:

  • To present clinical experience with Kawasaki disease in Chinese children.
  • To provide a basis for improved KD treatment strategies in the region.
  • To contribute to the limited data on KD in mainland China.

Main Methods:

  • Retrospective analysis of 170 children diagnosed with KD.
  • Data collected from Shaanxi People's Hospital, Xi'an, China.
  • Focus on clinical presentation and management experiences.

Main Results:

  • The study reports on 170 pediatric cases of Kawasaki disease.
  • This represents one of the largest single-center experiences from China to date.
  • Findings aim to inform clinical practice and future research.

Conclusions:

  • The findings underscore the growing incidence of KD in China.
  • This research provides valuable insights for managing KD in a Chinese pediatric population.
  • Further studies are needed to fully understand KD epidemiology and treatment outcomes in China.

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
735
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
483
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
441